Effect of supplementation in treatment of patients with diabetic hemodialysis

Phase 3

• Conditions: N18.5; Chronic kidney disease.; Chronic kidney disease, stage 5

• Registration Number: IRCT201701035623N101
• Lead Sponsor: Vice chancellor for research, Kashan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 17 December 2019

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Patients with diabetic hemodialysis
Aged 18 to 80 years

Exclusion Criteria

Taking vitamin D, antioxidant and anti-inflammatory supplements such as vitamins E and C, omega-3 fatty acids
Taking immunosuppressive medications within 3 months prior to the enrollment in the study

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
TNF-a. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: PCR.;IL-1. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: PCR.;IL-6. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: PCR.;IL-4. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: PCR.

Secondary Outcome Measures

Name	Time	Method
TGF-ß. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: PCR.;NFK-ß. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: PCR.;VEGF. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: PCR.;IFN-?. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: PCR.